Adjuvanted meningococcus compositions

Details Adjuvanted meningococcus compositions Adjuvanted meningococcus compositions

2002-10-03

2010-11-23

Devi, S. (Department: 1645)

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Bacterium or component thereof or substance produced by said...

C424S234100, C424S184100, C424S203100, C424S249100, C514S002600, C530S350000, C530S825000, C530S300000

Reexamination Certificate

active

07838015

ABSTRACT:
A combination of CpG oligonucleotides and polymer microparticles is an extremely effective adjuvant for Neisserial antigens. The invention therefore provides a composition comprising: (a) a Neisserial antigen; (b) a CpG oligonucleotide; and (c) a biodegradable polymer microparticle.

REFERENCES:
patent: 6884435 (2005-04-01), O'Hagan et al.
patent: WO 99/36544 (1999-07-01), None
patent: WO 99/57280 (1999-11-01), None
patent: WO 00/06123 (2000-02-01), None
patent: WO 00/50075 (2000-08-01), None
patent: 01/64920 (2001-09-01), None
patent: 01/64922 (2001-09-01), None
patent: 03/020756 (2003-03-01), None
Cruse et al. Illustrated Dictionary of Immunology. 2nd Edition, CRC Press, p. 46, 2003.
Colman PM. Research Immunol. 145: 33-36, 1994.
McGuinnes et al. Mol. Microbiol. 7: 505-514, 1993.
McGuinnes et al. Lancet 337: 514-517, 1991.
Singh M, et al: “Cationic Microparticles are an effective delivery system for immunie stimulatory CpG DNA” Pharmaceutical Research, New York, NY, US, vol. 18, No. 10, Oct. 2001, pp. 1476-1479, XP002976979 Issn: 0724-8741 * whole document *.
O'Hagan D T et al: “poly(lactide-co-glycolide) Microparticles for the development of single-dose controlled-release vaccines” Advanced drug delivery reviews, Amsterdam, NL., vol. 32, 1998, pp. 225-246, XP000944990 Issn: 0169-409X * abstract *.
Singh M, et al: “Advances in Vaccine Adjuvants” Nature Biotechnology, Nature Publishing Group, New York, NY, US, vol. 17, No. 11, Nov. 1999, pp. 1075-1081, XP000941305 Issn: 1087-0156 * the whole document *.
A. Spickler et al., “Adjuvants in Veterinary Vaccines: Modes of Action and Adverse Effects”, J Vet Intern Med 2003; 17:273-281.
J. Cox et al., “Adjuvants—A Classification and Review of Their Modes of Action”, Vaccine, vol. 15, No. 3, pp. 248-256, 1997.
N. Burdin et al., “Immunological Foundations to the Quest for New Vaccine Adjuvants”, Biodrugs 2004; 18 (2):79-93.

Affiliated with

Also associated with

Rating

Adjuvanted meningococcus compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Adjuvanted meningococcus compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Adjuvanted meningococcus compositions will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4211892